Siris Medical

Siris Medical, Inc., founded in 2013, is a trailblazer in AI-driven radiotherapy treatment decision support for cancer patients. Through its predictive software, the company enables real-time informed decision-making for clinicians in radiation oncology using Artificial Intelligence (AI). The firm's two commercial products, QuickMatch and 510(k)-cleared PlanMD, harness machine learning to link each new patient to a growing, market-leading oncology library of plan outcomes, aiming to set the standard of care in treatment decision-making. With its recent Venture Round investment in November 2020 led by WVV Capital, Siris Medical is poised to further solidify its position as a leader in AI-powered cancer treatment solutions within the Health Care industry. Based in the United States, the company continues to make significant strides in improving treatment delivery and outcomes for cancer patients undergoing radiation therapy.